1. Home
  2. CR vs BIO Comparison

CR vs BIO Comparison

Compare CR & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crane Company

CR

Crane Company

HOLD

Current Price

$174.37

Market Cap

10.0B

Sector

Industrials

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$273.14

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CR
BIO
Founded
1855
1952
Country
United States
United States
Employees
N/A
7450
Industry
Metal Fabrications
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.0B
7.1B
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
CR
BIO
Price
$174.37
$273.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$223.40
$358.50
AVG Volume (30 Days)
304.2K
241.3K
Earning Date
04-27-2026
04-30-2026
Dividend Yield
0.59%
N/A
EPS Growth
23.96
N/A
EPS
6.26
N/A
Revenue
$2,305,000,000.00
N/A
Revenue This Year
$28.11
$2.74
Revenue Next Year
$5.76
$3.05
P/E Ratio
$27.64
$9.72
Revenue Growth
8.16
N/A
52 Week Low
$127.04
$211.43
52 Week High
$214.31
$343.12

Technical Indicators

Market Signals
Indicator
CR
BIO
Relative Strength Index (RSI) 38.38 48.84
Support Level N/A $266.71
Resistance Level $187.13 $289.61
Average True Range (ATR) 5.91 7.69
MACD -1.13 1.39
Stochastic Oscillator 27.54 78.70

Price Performance

Historical Comparison
CR
BIO

About CR Crane Company

Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and advanced technologies, and process flow technologies. Crane generated approximately $2.3 billion in revenue in 2025.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: